600833 第一医药
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)4.63915.2609.14216.6686.532
总资产报酬率 ROA (%)2.6568.4864.5768.5113.619
投入资产回报率 ROIC (%)3.46311.1356.09811.6145.222

边际利润分析
销售毛利率 (%)16.28516.63019.10120.52517.737
营业利润率 (%)4.12310.8645.4387.1782.513
息税前利润/营业总收入 (%)4.15310.5616.1537.1993.310
净利润/营业总收入 (%)3.5108.5434.9075.4053.534

收益指标分析
经营活动净收益/利润总额(%)4.3243.03823.417118.75746.756
价值变动净收益/利润总额(%)12.7776.14320.3082.3132.976
营业外收支净额/利润总额(%)9.5023.79115.791-0.05946.138

偿债能力分析
流动比率 (X)1.7061.7391.6511.5081.492
速动比率 (X)1.1271.2201.1601.1471.009
资产负债率 (%)42.37042.20445.87452.98541.705
带息债务/全部投入资本 (%)14.11214.19314.96428.2555.102
股东权益/带息债务 (%)536.073518.897482.544218.5471,623.254
股东权益/负债合计 (%)134.909135.894117.16788.083138.520
利息保障倍数 (X)-10.309-14.425-20.157277.658-2.442

营运能力分析
应收账款周转天数 (天)31.71240.54447.48525.18234.033
存货周转天数 (天)77.84575.37081.56346.83867.300